Based in Andover, Massachusetts, the company helps hospitals and other healthcare organizations connect devices and EHRs through its vendor-neutral system. 

Last Tuesday the FDA posted an action plan telling how it will evaluate AI for medical applications going forward. Three days later the agency officially proposed letting numerous products through without review. 

Patients who received a more intense course of evaluation tallied $20,132 more in expenditures, but saw no difference in late-stage cancer diagnoses, experts wrote in JAMA.

Plus, Johns Hopkins radiologist joins scientific advisory board, new interventional rad leadership, and Strategic Radiology's latest C-suite hire.

Case complexity also plummeted in several key categories during the pandemic peak, with implications for future budgeting and resource allocation, experts advised. 

Combining the Lung CT Screening Reporting and Data System with AI-based malignancy risk scoring bolstered exam specificity up to 96%, compared to 66% when using Lung-RADS alone.

If the hospitals of America’s most populous city are any sort of bellwether, CMS is going to have its hands full trying to enforce compliance with the Trump Administration’s executive order on price transparency.

That’s according to a large, retrospective analysis of this intervention, detailed in RSNA’s Radiology.